Cholesterol-lowering Action of BNA-based Antisense Oligonucleotides Targeting PCSK9 in Atherogenic Diet-induced Hypercholesterolemic Mice

Recent findings in molecular biology implicate the involvement of proprotein convertase subtilisin/kexin type 9 (PCSK9) in low-density lipoprotein receptor (LDLR) protein regulation. The cholesterol-lowering potential of anti-PCSK9 antisense oligonucleotides (AONs) modified with bridged nucleic acid...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Yamamoto, Tsuyoshi, Harada-Shiba, Mariko, Nakatani, Moeka, Wada, Shunsuke, Yasuhara, Hidenori, Narukawa, Keisuke, Sasaki, Kiyomi, Shibata, Masa-Aki, Torigoe, Hidetaka, Yamaoka, Tetsuji, Imanishi, Takeshi, Obika, Satoshi
Format: Artigo
Sprache:Inglês
Veröffentlicht: Nature Publishing Group 2012
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3393380/
https://ncbi.nlm.nih.gov/pubmed/23344002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mtna.2012.16
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge